Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04459117Phase 2Completed

Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen

Role: collaborator

NCT07134387Recruiting

Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)

Role: lead

NCT06827028Not Yet Recruiting

Global Survey on Newborns' HOspitalisation and Parental Experiences - the HOPE Study

Role: lead

NCT06379828Not Yet Recruiting

Self-assessment Tool for Implementing the ESCNH

Role: lead

NCT05550545Unknown

Infant RSV Infections and Health-related Quality of Life of Families

Role: lead

All 5 trials loaded